Insights into nanoparticle surface bonding and coating architecture via multinuclear NMR.

Tantalum oxide nanoparticles (TaO NPs) are promising as high--contrast agents for computed tomography (CT) due to their profound imaging benefits relative to those of clinical iodinated contrast media (ICM) at the X-ray tube voltages ≥100 kVp required for most patients. Furthermore, TaO NPs have prevailed through extensive non-GLP and GLP (good laboratory practice) preclinical development, including in vivo/vitro safety testing and imaging efficacy studies. This is due in part to innovative structural engineering of the NPs' core size and coating, which has been shown to provide favorable pharmacokinetics and promote rapid renal clearance, with negligible organ retention.